News : Kayentis software for clinical trials
Kayentis identified as a key stakeholder by the governmental report on Key Technologies for 2015
The governmental report Key Technologies for 2015 identified Kayentis as amongst the primary French stakeholders specialising in human/machine interfaces thanks to its Digital Pen & Paper solutions.
The Ministry for Economy, Finance and Industry reported in its study into Key Technologies for 2015 that one of the major challenges for Information and Communication Technologies shall be that of providing a response to the issue of the ageing population. So as to better take charge of the third and fourth age members of the population, it is important to improve their quality of life by enabling their entourage (carers, doctors, family members, etc.) to have improved access to information, traceability of initiatives and better management of personal risks. Proposing solutions intended for many healthcare and pharmaceutical sectors, Kayentis has been identified as a strategic stakeholder able to fulfil these objectives.
Using Digital Pen & Paper technology, Kayentis solutions combine the very best of the physical and digital worlds: the simplest data collection methods, for dependents and for stakeholders in the medical and social settings (digital pen and paper solutions), offering the highest quality data; combined with a whole host of advantages pertaining to electronic data management (real-time access to data, precise parametering, alerts, collaborative workflow, etc.). These solutions enable all parties involved in the healthcare of an individual to be inter-connected and coordinated in the most natural and rapid manner possible. All of these advantages contribute towards better understanding and anticipating the needs of dependents.
Through its convivial nature, the digital pen and paper solution is today the best method of including everyone and therefore of accelerating the adoption of new technologies in the healthcare setting. Thanks to its groundbreaking solutions, Kayentis combines ease of use and complex technology.
About the Key Technologies for 2015 study
The purpose of the study entitled Key Technologies for 2015 is to outline the strategic segments in our economy and to analyse the strengths and weaknesses in the development of these technologies in France. The most relevant organisations have each been united in each of the sectors object of the study so as to ensure that the report entitled Key Technologies for 2015 represents a strategic analysis which can serve as a basis for future organisation. Key Technologies for 2015 is therefore the result of many exchanges organised with more than 250 specialists, experts, and representatives from the socio-economic world into the challenges faced by our society both nationally and on the global market.
Kayentis is the #1 publisher and operator of digital pen and smart paper solutions for the healthcare industry. These solutions, based on the Kayentis Digital Pen & Paper platform, combine the best of the physical and digital worlds: a very simple collection method (paper and pen) that offers the highest data reliability, plus all the advantages of electronic management (real-time data access, precise timestamping, audit trail features, alerts, and transmission of relevant information to each stakeholder). Today, Kayentis solutions have been successfully deployed in 50 countries for more than 50,000 patients. Kayentis solutions are based on Anoto Digital Pen & Paper technology; Kayentis is one of the leading world partners of Anoto, and is certified Anoto Platinum Partner. Kayentis is a member of the Pennsylvania BIO and BIO New Jersey clusters. Kayentis is an Anoto Platinum Partner, Oracle Partner and HP Solution Business Partner.